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It’s now cheaper to print color figures in KI
Have you been concerned in the past about the cost of print-
ing color figures in Kidney International (KI)? KI has listened 
to your concerns and is now offering permanently reduced 
pricing for color figures—a flat fee of $500 per printed page, 
no matter how many color figures are on a page. This pricing 
is more affordable for authors and competitive with other top 
scientific journals. We want to make it easier for authors to 
publish the color figures that demonstrate important scien-
tific findings, and our new pricing reflects our commitment to 
achieving this goal.
Pathways of 
muscle atrophy 
and hypertrophy 
in chronic kidney 
disease 
Muscle atrophy is a major problem in 
chronic renal failure, so Verzola et al. 
studied the potential mechanism by 
which this atrophy occurs in uremic 
patients. They obtained muscle biopsies 
from patients with stage 5 chronic kid-
ney disease and measured the expression 
of myostatin and evidence of apoptosis 
using the TUNEL assay. They found that 
apoptosis, by this method, increased as 
much as fivefold. Similarly, the expression 
of myostatin and interleukin-6 was also 
increased, as both of these are mediators 
of muscle atrophy. On the other hand, 
insulin-like growth factor-I (IGF-I) was 
lower than in controls. Phospho-Akt, a 
downstream kinase of IGF-I, was down-
regulated, whereas phospho-JNK and 
c-Jun were elevated. These studies show 
that the pathways that mediate muscle 
atrophy are activated and those that 
support muscle hypertrophy are down-
regulated. See page 773.
Vitamin D and  
the kidney
In this issue, we have three articles that 
review the most recent developments 
in research on the role of vitamin D 
in kidney diseases. Razzaque reviews 
the difficult subject of vitamin D’s role 
in vascular calcification. Accelerated 
atherosclerosis and calcification is the 
number one cause of morbidity and 
mortality in end-stage renal disease, 
and the role of vitamin D here is vex-
ing. On the one hand, deficiency of the 
hormone is associated with calcification, 
but on the other hand, overabundance 
causes hypercalcemia, which tends to 
favor calcification, too. Razzaque puts 
forth the moderate suggestion that the 
control of plasma phosphate is prob-
ably the best approach. Cunningham 
and Zehnder review the new vitamin 
D analogs that bind to the receptor but 
seem to have fewer side effects than 
the classic hormone itself. In the third 
article, Dusso and Tokumoto review 
the pathophysiology of vitamin D defi-
ciency in renal failure and the role of 
replacement in improving survival. See 
pages 702, 708, and 715.
High-protein diet 
in infancy increases 
kidney size
Protein intake clearly affects kidney 
growth and glomerular filtration rate. 
Escribano et al. studied the influence 
of different protein intakes on infants 
assigned a low-protein or a high-protein 
formula diet. In addition, these infants 
were compared with a set of infants who 
were breastfed. Using ultrasound, the 
authors found that at 6 months, infants 
fed a high-protein diet had larger kid-
neys than those on a low-protein diet. 
The breastfed infants had the same-
sized kidneys as the low-protein-diet 
infants. These results clearly show that 
the early effects of a high-protein diet 
are significant and measurable, causing 
larger kidneys than low-protein diets 
and breastfeeding. The implications of 
these findings will become apparent 
only with much longer follow-up of 
these subjects. See page 783.
